MRI predictors of pharmacotherapy response in major depressive disorder

MRI predictors of pharmacotherapy response in major depressive disorder

Major depressive disorder is among the most prevalent psychiatric disorders, exacting a substantial personal, social, and economic toll. Antidepressant treatment typically involves an individualized trial and error approach with an inconsistent success rate. Despite a pressing need, no reliable biom...

Full description

Bibliographic Details
Main Authors:	Andrew R. Gerlach, Helmet T. Karim, Marta Peciña, Olusola Ajilore, Warren D. Taylor, Meryl A. Butters, Carmen Andreescu
Format:	Article
Language:	English
Published:	Elsevier 2022-01-01
Series:	NeuroImage: Clinical
Subjects:	Major depressive disorder MRI Antidepressant Response Prediction
Online Access:	http://www.sciencedirect.com/science/article/pii/S2213158222002224

Similar Items

Functional connectivity of brain structures correlates with treatment outcome in Major Depressive Disorder
by: F. Andrew eKozel, et al.
Published: (2011-03-01)

Predictors of the effectiveness of an early medication change strategy in patients with major depressive disorder
by: Nadine Dreimüller, et al.
Published: (2019-01-01)

Less basal thyrotropin levels predict antidepressant response in patients with major depression
by: R. Navinés, et al.
Published: (2022-06-01)

Acute trajectories of neural activation predict remission to pharmacotherapy in late-life depression
by: Helmet T. Karim, et al.
Published: (2018-01-01)

Clinical Guideline (CANMAT 2016) Discordance of Medications for Patients with Major Depressive Disorder in China
by: Zhu Y, et al.
Published: (2023-04-01)

The effects of physiotherapy methods combined with respiratory and relaxation exercises on patients with major depression
by: Elisa Calisgan, et al.
Published: (2020-12-01)

Exploring the Role and Potential of Probiotics in the Field of Mental Health: Major Depressive Disorder
by: Dinyadarshini Johnson, et al.
Published: (2021-05-01)

Psychotherapy employed additionally to Psychopharmacotherapy is not related to Better Treatment Outcome in Major Depressive Disorder
by: L. Bartova, et al.
Published: (2022-06-01)

Tricyclic antidepressants for major depressive disorder: a comprehensive evaluation of current practice in the Netherlands
by: Cornelis F. Vos, et al.
Published: (2021-10-01)

Does the use of pharmacotherapy interact with the effects of psychotherapy? A meta-analytic review
by: Pim Cuijpers, et al.
Published: (2023-01-01)

A study to identify unrecognized bipolar disorder in patients of major depressive disorder taking antidepressants
by: Kinjal Bhupendrasinh Chauhan, et al.
Published: (2022-12-01)

Grant Report on the Transcranial near Infrared Radiation and Cerebral Blood Flow in Depression (TRIADE) Study
by: Dan V. Iosifescu, et al.
Published: (2023-01-01)

Program of algorithm for pharmacological treatment of major depressive disorder in China: Benefits or not?
by: Yuncheng Zhu, et al.
Published: (2023-11-01)

Tricyclic antidepressants versus ‘active placebo’, placebo or no intervention for adults with major depressive disorder: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis
by: Caroline Kamp Jørgensen, et al.
Published: (2021-08-01)

Taking the perspective that a depressive state reflects inflammation: implications for the use of antidepressants
by: Jill Leslie Littrell
Published: (2012-08-01)

The Efficacy of Vortioxetine on Anhedonia in Patients With Major Depressive Disorder
by: Bing Cao, et al.
Published: (2019-01-01)

Clinical perspectives on the influence of drug formulation on patient tolerability and use of commonly prescribed antidepressants in major depressive disorder
by: Matthew A Fuller, et al.
Published: (2013-01-01)

Clinical Phenotypes Characterization in Pharmacogenetics Testing Trials for Major Depressive Disorder Treatment
by: A. Minelli
Published: (2022-06-01)

Addition of aerobic exercise to antidepressant drug monotherapy for major depressive disorder in adults
by: Camila Sanhueza Pastén, et al.
Published: (2022-01-01)

Multi-omics reveal microbial determinants impacting the treatment outcome of antidepressants in major depressive disorder
by: Yaping Wang, et al.
Published: (2023-08-01)

Functional connectivity analysis on electroencephalography signals reveals potential biomarkers for treatment response in major depression
by: Shiau-Shian Huang, et al.
Published: (2023-08-01)

Functional connectivity of the amygdala and the antidepressant and antisuicidal effects of repeated ketamine infusions in major depressive disorder
by: Haiyan Liu, et al.
Published: (2023-02-01)

The role of pharmacogenetics in the treatment of major depressive disorder: a critical review
by: Stefano Barlati, et al.
Published: (2023-11-01)

The Impact of Residual Symptoms in Major Depression
by: Joshua A. Israel
Published: (2010-08-01)

Recognition of Facial Emotion Expressions in Patients with Depressive Disorders: A Functional MRI Study
by: Sergey Ternovoy, et al.
Published: (2023-02-01)

Exploring the Role of Gut Microbiota in Major Depressive Disorder and in Treatment Resistance to Antidepressants
by: Andrea Fontana, et al.
Published: (2020-08-01)

Blue again: Perturbational effects of antidepressants suggest monoaminergic homeostasis in major depression
by: Paul eAndrews, et al.
Published: (2011-07-01)

Uncovering the Roles of MicroRNAs in Major Depressive Disorder: From Candidate Diagnostic Biomarkers to Treatment Response Indicators
by: Claudia Homorogan, et al.
Published: (2021-10-01)

Modern approaches to the pharmacotherapy of postpartum depression
by: A. V. Ovchinnikov, et al.
Published: (2020-08-01)

The influence of general practitioner and patient sex on the treatment of major depression
by: Elisabeth Jufresa-Blanch, et al.
Published: (2023-11-01)

From Serotonin to Neuroplasticity: Evolvement of Theories for Major Depressive Disorder
by: Bangshan Liu, et al.
Published: (2017-09-01)

Cortisol and Major Depressive Disorder—Translating Findings From Humans to Animal Models and Back
by: L. Sanjay Nandam, et al.
Published: (2020-01-01)

Psychotherapy, pharmacotherapy, and their combination in the treatment of major depressive disorder: How well are we making use of available therapies?
by: Nădășan Ingrid Karina, et al.
Published: (2023-12-01)

Prediction of early improvement of major depressive disorder to antidepressant medication in adolescents with radiomics analysis after ComBat harmonization based on multiscale structural MRI
by: Huan Ma, et al.
Published: (2023-06-01)

Striatal Functional Connectivity Alterations After Two-Week Antidepressant Treatment Associated to Enduring Clinical Improvement in Major Depressive Disorder
by: Jing An, et al.
Published: (2019-12-01)

Functional connectivity of the amygdala subregions and the antidepressant effects of repeated ketamine infusions in major depressive disorder
by: Haiyan Liu, et al.
Published: (2024-01-01)

The Potential of Scopolamine as an Antidepressant in Major Depressive Disorder: A Systematic Review of Randomized Controlled Trials
by: Paweł Moćko, et al.
Published: (2023-09-01)

Treatment patterns in major depressive disorder after an inadequate response to first-line antidepressant treatment
by: Garcia-Toro Mauro, et al.
Published: (2012-09-01)

Short- and Long-Term Antidepressant Clinical Trials for Major Depressive Disorder in Youth: Findings and Concerns
by: Daniel J. Safer, et al.
Published: (2019-10-01)

Heart Rate Variability for the Prediction of Treatment Response in Major Depressive Disorder
by: Kwan Woo Choi, et al.
Published: (2020-06-01)